Oruka Therapeutics, Inc. (ORKA) Operating profit

annual operating profit:

-$88.12M-$80.83M(-1107.83%)
December 31, 2024

Summary

  • As of today (September 10, 2025), ORKA annual operating income is -$88.12 million, with the most recent change of -$80.83 million (-1107.83%) on December 31, 2024.
  • During the last 3 years, ORKA annual operating profit has fallen by -$68.79 million (-355.77%).
  • ORKA annual operating profit is now -1940.36% below its all-time high of -$4.32 million, reached on December 1, 2012.

Performance

ORKA Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherORKAincome statement metrics

quarterly operating profit:

-$28.43M-$3.34M(-13.33%)
June 30, 2025

Summary

  • As of today (September 10, 2025), ORKA quarterly operating income is -$28.43 million, with the most recent change of -$3.34 million (-13.33%) on June 30, 2025.
  • Over the past year, ORKA quarterly operating profit has dropped by -$6.94 million (-32.27%).
  • ORKA quarterly operating profit is now -200.04% below its all-time high of $28.42 million, reached on June 1, 2007.

Performance

ORKA quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherORKAincome statement metrics

TTM operating profit:

-$113.28M-$6.94M(-6.52%)
June 30, 2025

Summary

  • As of today (September 10, 2025), ORKA TTM operating income is -$113.28 million, with the most recent change of -$6.94 million (-6.52%) on June 30, 2025.
  • Over the past year, ORKA TTM operating profit has dropped by -$81.40 million (-255.31%).
  • ORKA TTM operating profit is now -3262.48% below its all-time high of -$3.37 million, reached on March 1, 2008.

Performance

ORKA TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherORKAincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

ORKA Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1107.8%-32.3%-255.3%
3 y3 years-355.8%-1070.4%-603.5%
5 y5 years-1415.7%-2070.2%-1814.2%

ORKA Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1107.8%at low-1695.9%+6.2%-1492.4%at low
5 y5-year-1415.7%at low-1695.9%+6.2%-1814.2%at low
alltimeall time-1940.4%+37.3%-200.0%+37.0%-3262.5%+2.7%

ORKA Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$28.43M(+13.3%)
-$113.28M(+6.5%)
Mar 2025
-
-$25.09M(-17.3%)
-$106.35M(+20.7%)
Dec 2024
-$88.12M(+1107.8%)
-$30.32M(+3.0%)
-$88.12M(+48.4%)
Sep 2024
-
-$29.45M(+37.0%)
-$59.40M(+86.3%)
Jun 2024
-
-$21.49M(+213.2%)
-$31.88M(+157.9%)
Mar 2024
-
-$6.86M(+331.6%)
-$12.36M(+69.4%)
Dec 2023
-$7.30M(-25.9%)
-
-
Dec 2023
-
-$1.59M(-17.9%)
-$7.30M(+0.1%)
Sep 2023
-
-$1.94M(-1.8%)
-$7.29M(+2.5%)
Jun 2023
-
-$1.97M(+9.9%)
-$7.11M(-6.0%)
Mar 2023
-
-$1.80M(+13.5%)
-$7.57M(-16.4%)
Dec 2022
-$9.84M(-49.1%)
-
-
Dec 2022
-
-$1.58M(-10.2%)
-$9.05M(-31.2%)
Sep 2022
-
-$1.76M(-27.5%)
-$13.15M(-18.3%)
Jun 2022
-
-$2.43M(-25.9%)
-$16.10M(-13.0%)
Mar 2022
-
-$3.28M(-42.3%)
-$18.51M(-4.3%)
Dec 2021
-$19.34M(+98.0%)
-
-
Dec 2021
-
-$5.68M(+20.4%)
-$19.34M(+2.9%)
Sep 2021
-
-$4.72M(-2.5%)
-$18.78M(+17.0%)
Jun 2021
-
-$4.84M(+17.9%)
-$16.05M(+28.2%)
Mar 2021
-
-$4.10M(-20.0%)
-$12.53M(+28.3%)
Dec 2020
-$9.77M(+68.0%)
-$5.13M(+157.6%)
-$9.77M(+65.0%)
Sep 2020
-
-$1.99M(+51.9%)
-$5.92M(+14.4%)
Jun 2020
-
-$1.31M(-2.2%)
-$5.17M(-3.7%)
Mar 2020
-
-$1.34M(+4.9%)
-$5.37M(-7.6%)
Dec 2019
-$5.81M(-28.4%)
-$1.28M(+2.5%)
-$5.81M(-4.1%)
Sep 2019
-
-$1.25M(-17.3%)
-$6.06M(-6.4%)
Jun 2019
-
-$1.51M(-15.3%)
-$6.48M(-9.1%)
Mar 2019
-
-$1.78M(+16.6%)
-$7.13M(-12.2%)
Dec 2018
-$8.12M(-56.6%)
-$1.53M(-8.1%)
-$8.12M(-25.4%)
Sep 2018
-
-$1.66M(-22.9%)
-$10.89M(-20.5%)
Jun 2018
-
-$2.16M(-22.3%)
-$13.70M(-19.9%)
Mar 2018
-
-$2.77M(-35.5%)
-$17.10M(-8.6%)
Dec 2017
-$18.71M(+12.6%)
-$4.30M(-4.0%)
-$18.71M(+0.0%)
Sep 2017
-
-$4.47M(-19.5%)
-$18.71M(-1.3%)
Jun 2017
-
-$5.56M(+26.9%)
-$18.94M(+9.3%)
Mar 2017
-
-$4.38M(+2.1%)
-$17.33M(+4.3%)
Dec 2016
-$16.61M(+45.0%)
-$4.29M(-8.9%)
-$16.61M(+7.2%)
Sep 2016
-
-$4.71M(+19.6%)
-$15.50M(+13.9%)
Jun 2016
-
-$3.94M(+7.4%)
-$13.60M(+9.9%)
Mar 2016
-
-$3.67M(+15.5%)
-$12.38M(+8.1%)
Dec 2015
-$11.46M(+18.2%)
-$3.17M(+12.7%)
-$11.46M(+5.2%)
Sep 2015
-
-$2.82M(+3.6%)
-$10.89M(+5.1%)
Jun 2015
-
-$2.72M(-0.9%)
-$10.36M(+3.1%)
Mar 2015
-
-$2.74M(+5.1%)
-$10.05M(+3.7%)
Dec 2014
-$9.69M(+39.7%)
-$2.61M(+14.3%)
-$9.69M(-3.3%)
Sep 2014
-
-$2.29M(-5.0%)
-$10.03M(+5.9%)
Jun 2014
-
-$2.41M(+0.7%)
-$9.47M(+14.6%)
Mar 2014
-
-$2.39M(-18.9%)
-$8.26M(+19.0%)
Dec 2013
-$6.94M
-$2.95M(+70.8%)
-$6.94M(+43.6%)
Sep 2013
-
-$1.73M(+44.0%)
-$4.83M(+19.8%)
Jun 2013
-
-$1.20M(+12.0%)
-$4.04M(+1.3%)
DateAnnualQuarterlyTTM
Mar 2013
-
-$1.07M(+27.5%)
-$3.98M(-7.8%)
Dec 2012
-$4.32M(-41.3%)
-$839.00K(-9.6%)
-$4.32M(-15.5%)
Sep 2012
-
-$928.00K(-19.0%)
-$5.11M(-14.9%)
Jun 2012
-
-$1.15M(-18.6%)
-$6.01M(-8.5%)
Mar 2012
-
-$1.41M(-14.0%)
-$6.57M(-10.8%)
Dec 2011
-$7.36M(-19.8%)
-$1.63M(-10.3%)
-$7.36M(-8.9%)
Sep 2011
-
-$1.82M(+6.9%)
-$8.08M(-3.4%)
Jun 2011
-
-$1.70M(-22.6%)
-$8.36M(-6.3%)
Mar 2011
-
-$2.20M(-6.4%)
-$8.93M(-2.7%)
Dec 2010
-$9.18M(-59.8%)
-$2.35M(+11.7%)
-$9.18M(-1.0%)
Sep 2010
-
-$2.11M(-7.2%)
-$9.27M(-9.8%)
Jun 2010
-
-$2.27M(-7.3%)
-$10.29M(-33.1%)
Mar 2010
-
-$2.45M(-0.0%)
-$15.38M(-32.7%)
Dec 2009
-$22.85M(+17.2%)
-$2.45M(-21.5%)
-$22.85M(-10.4%)
Sep 2009
-
-$3.12M(-57.7%)
-$25.49M(-11.5%)
Jun 2009
-
-$7.37M(-25.7%)
-$28.80M(+13.3%)
Mar 2009
-
-$9.92M(+94.7%)
-$25.41M(+30.4%)
Dec 2008
-$19.49M(+17.7%)
-$5.09M(-20.7%)
-$19.49M(-32.7%)
Sep 2008
-
-$6.42M(+61.4%)
-$28.96M(-19.0%)
Jun 2008
-
-$3.98M(-0.4%)
-$35.77M(+961.7%)
Mar 2008
-
-$4.00M(-72.6%)
-$3.37M(-79.6%)
Dec 2007
-$16.55M(-88.2%)
-$14.56M(+10.0%)
-$16.55M(-64.9%)
Sep 2007
-
-$13.23M(-146.6%)
-$47.13M(-25.1%)
Jun 2007
-
$28.42M(-265.4%)
-$62.96M(-44.0%)
Mar 2007
-
-$17.18M(-61.9%)
-$112.33M(-3.5%)
Dec 2006
-$140.57M(+92.5%)
-$45.13M(+55.3%)
-$116.39M(+25.7%)
Sep 2006
-
-$29.07M(+38.7%)
-$92.62M(+12.4%)
Jun 2006
-
-$20.95M(-1.4%)
-$82.40M(+4.5%)
Mar 2006
-
-$21.24M(-0.5%)
-$78.89M(+8.9%)
Dec 2005
-$73.04M(+50.7%)
-$21.36M(+13.3%)
-$72.47M(+17.1%)
Sep 2005
-
-$18.85M(+8.1%)
-$61.90M(+16.1%)
Jun 2005
-
-$17.44M(+17.6%)
-$53.32M(+14.6%)
Mar 2005
-
-$14.83M(+37.6%)
-$46.51M(-4.4%)
Dec 2004
-$48.48M(+1.0%)
-$10.78M(+4.9%)
-$48.67M(+2.9%)
Sep 2004
-
-$10.27M(-3.4%)
-$47.29M(-1.4%)
Jun 2004
-
-$10.63M(-37.4%)
-$47.97M(-7.6%)
Mar 2004
-
-$16.98M(+80.6%)
-$51.88M(+7.4%)
Dec 2003
-$48.02M(+14.7%)
-$9.40M(-14.1%)
-$48.31M(-12.4%)
Sep 2003
-
-$10.95M(-24.8%)
-$55.13M(+22.0%)
Jun 2003
-
-$14.55M(+8.5%)
-$45.17M(+19.3%)
Mar 2003
-
-$13.41M(-17.3%)
-$37.86M(-12.5%)
Dec 2002
-$41.87M(+22.1%)
-$16.22M(+1541.4%)
-$43.29M(+15.3%)
Sep 2002
-
-$988.00K(-86.4%)
-$37.54M(-17.7%)
Jun 2002
-
-$7.24M(-61.5%)
-$45.63M(-2.4%)
Mar 2002
-
-$18.84M(+80.0%)
-$46.73M(+36.3%)
Dec 2001
-$34.28M(+50.8%)
-$10.47M(+15.3%)
-$34.28M(+12.6%)
Sep 2001
-
-$9.08M(+8.8%)
-$30.44M(+42.5%)
Jun 2001
-
-$8.35M(+30.7%)
-$21.36M(+64.2%)
Mar 2001
-
-$6.39M(-3.6%)
-$13.01M(+96.4%)
Dec 2000
-$22.73M(+14.4%)
-$6.63M(+25.4%)
-$6.63M(+25.4%)
Dec 1999
-$19.86M(+3.9%)
-$5.29M
-$5.29M
Dec 1998
-$19.11M
-
-

FAQ

  • What is Oruka Therapeutics, Inc. annual operating income?
  • What is the all time high annual operating profit for Oruka Therapeutics, Inc.?
  • What is Oruka Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Oruka Therapeutics, Inc. quarterly operating income?
  • What is the all time high quarterly operating profit for Oruka Therapeutics, Inc.?
  • What is Oruka Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Oruka Therapeutics, Inc. TTM operating income?
  • What is the all time high TTM operating profit for Oruka Therapeutics, Inc.?
  • What is Oruka Therapeutics, Inc. TTM operating profit year-on-year change?

What is Oruka Therapeutics, Inc. annual operating income?

The current annual operating profit of ORKA is -$88.12M

What is the all time high annual operating profit for Oruka Therapeutics, Inc.?

Oruka Therapeutics, Inc. all-time high annual operating income is -$4.32M

What is Oruka Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, ORKA annual operating income has changed by -$80.83M (-1107.83%)

What is Oruka Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of ORKA is -$28.43M

What is the all time high quarterly operating profit for Oruka Therapeutics, Inc.?

Oruka Therapeutics, Inc. all-time high quarterly operating income is $28.42M

What is Oruka Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, ORKA quarterly operating income has changed by -$6.94M (-32.27%)

What is Oruka Therapeutics, Inc. TTM operating income?

The current TTM operating profit of ORKA is -$113.28M

What is the all time high TTM operating profit for Oruka Therapeutics, Inc.?

Oruka Therapeutics, Inc. all-time high TTM operating income is -$3.37M

What is Oruka Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, ORKA TTM operating income has changed by -$81.40M (-255.31%)
On this page